AssetMark Inc
MEDP icon

AssetMark Inc’s Medpace MEDP Stock Holding History

AssetMark Inc’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.9K Sell
115
-3
-3% -$1.39K ﹤0.01% 1770
2026
Q1 		$56.7K Sell
118
-52
-31% -$26.6K ﹤0.01% 1717
2025
Q4 		$95.5K Sell
170
-44
-21% -$25K ﹤0.01% 1506
2025
Q3 		$110K Sell
214
-18
-8% -$7.86K ﹤0.01% 1411
2025
Q2 		$72.8K Buy
232
+16
+7% +$4.8K ﹤0.01% 1440
2025
Q1 		$65.8K Buy
216
+43
+25% +$14.5K ﹤0.01% 1370
2024
Q4 		$57.5K Buy
173
+29
+20% +$9.84K ﹤0.01% 1393
2024
Q3 		$48.1K Sell
144
-43
-23% -$16.3K ﹤0.01% 1299
2024
Q2 		$77K Buy
187
+11
+6% +$4.36K ﹤0.01% 1149
2024
Q1 		$71.1K Sell
176
-44
-20% -$15.5K ﹤0.01% 1100
2023
Q4 		$67.4K Hold
220
– – ﹤0.01% 1101
2023
Q3 		$53.3K Hold
220
– – ﹤0.01% 1084
2023
Q2 		$52.8K Hold
220
– – ﹤0.01% 1059
2023
Q1 		$41.4K Hold
220
– – ﹤0.01% 1075
2022
Q4 		$46.7K Hold
220
– – ﹤0.01% 1057
2022
Q3 		$35K Sell
220
-105
-32% -$16.8K ﹤0.01% 1020
2022
Q2 		$49K Sell
325
-85
-21% -$12.3K ﹤0.01% 918
2022
Q1 		$67K Hold
410
– – ﹤0.01% 860
2021
Q4 		$89K Sell
410
-16
-4% -$3.35K ﹤0.01% 808
2021
Q3 		$81K Hold
426
– – ﹤0.01% 689
2021
Q2 		$75K Buy
426
+10
+2% +$1.73K ﹤0.01% 689
2021
Q1 		$68K Buy
416
+50
+14% +$7.65K ﹤0.01% 685
2020
Q4 		$51K Buy
366
+361
+7,220% +$45.5K ﹤0.01% 710
2020
Q3 		$1K Hold
5
– – ﹤0.01% 1250
2020
Q2 		$0 Sell
5
-2
-29% -$170 ﹤0.01% 1378
2020
Q1 		$1K Sell
7
-24
-77% -$2.08K ﹤0.01% 1273
2019
Q4 		$3K Buy
31
+2
+7% +$155 ﹤0.01% 1185
2019
Q3 		$2K Buy
29
+19
+190% +$1.44K ﹤0.01% 1174
2019
Q2 		$1K Buy
10
+4
+67% +$231 ﹤0.01% 1250
2019
Q1 		$0 Buy
+6
New +$358 ﹤0.01% 1453

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AssetMark Inc's MEDP Position: Q2 2026 in Review

AssetMark Inc reduced its Medpace (MEDP) stake by 2.5% in Q2 2026, selling an estimated $1.39K and leaving 115 shares worth $60.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1770.

AssetMark Inc first reported a position in MEDP in Q1 2019 and has held it in 30 quarters since. The position peaked at $110K in Q3 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • AssetMark Inc held 115 shares of Medpace worth $60.9K as of Q2 2026.
  • AssetMark Inc sold 3 Medpace shares in Q2 2026, an estimated $1.39K.
  • Medpace made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1770 holding.
  • AssetMark Inc first reported a position in Medpace in Q1 2019 and has held it in 30 quarters since.
  • AssetMark Inc's Medpace position peaked at $110K in Q3 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.